EGIS-7625

From WikiMD's Wellnesspedia

EGIS-7625


EGIS-7625 is a chemical compound that belongs to the class of pharmacological agents known as antipsychotic drugs. It is primarily used in the treatment of various mental disorders, including schizophrenia and bipolar disorder.

History[edit | edit source]

EGIS-7625 was first synthesized by EGIS Pharmaceuticals, a Hungary-based pharmaceutical company. The compound was developed as part of the company's ongoing research into novel antipsychotic agents.

Pharmacology[edit | edit source]

EGIS-7625 acts by modulating the activity of certain neurotransmitters in the brain, particularly dopamine and serotonin. It is thought to work by blocking the receptors for these neurotransmitters, thereby reducing their activity. This can help to alleviate the symptoms of mental disorders such as schizophrenia and bipolar disorder.

Clinical Use[edit | edit source]

EGIS-7625 is used in the treatment of a range of mental disorders. It is particularly effective in managing the symptoms of schizophrenia, including hallucinations, delusions, and disorganized thinking. It can also be used to treat the manic and depressive episodes associated with bipolar disorder.

Side Effects[edit | edit source]

Like all antipsychotic drugs, EGIS-7625 can cause a range of side effects. These can include drowsiness, dizziness, and nausea. In rare cases, it can also cause more serious side effects such as tardive dyskinesia, a condition characterized by involuntary movements of the face and body.

See Also[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD